How many insider declarations has McBride John S. filed?

McBride John S. has filed 1 public insider declaration with SEC (Form 4).

What is McBride John S.'s role?

McBride John S.'s reported role is not specified by the regulator across the filings.

Which companies does McBride John S. report trades for?

McBride John S. reports trades for Eledon Pharmaceuticals, Inc..

← Executives ★ Sign in to follow

MJ

McBride John S.

OFFICERM

·SEC (Form 4)

Eledon Pharmaceuticals, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by McBride John S.. Officer active across 1 company, notably Eledon Pharmaceuticals, Inc.. Cumulatively, 1 filings have been published. Activity tracked since 10 January 2026. The latest transaction was disclosed on 10 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to McBride John S.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Eledon Pharmaceuticals, Inc. (US)

申报1 总计

◇

McBride John S.

Director高管2026年1月10日Eledon Pharmaceuticals, Inc.

0SEC ↗

3,430 股0Common StockSEC:0001193125-26-015489:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MJ

McBride John S.

OFFICERM

·SEC (Form 4)

Eledon Pharmaceuticals, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by McBride John S.. Officer active across 1 company, notably Eledon Pharmaceuticals, Inc.. Cumulatively, 1 filings have been published. Activity tracked since 10 January 2026. The latest transaction was disclosed on 10 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.